Page last updated: 2024-08-24

aripiprazole and Deficiency, Mental

aripiprazole has been researched along with Deficiency, Mental in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (38.46)29.6817
2010's6 (46.15)24.3611
2020's2 (15.38)2.80

Authors

AuthorsStudies
Anand, G; Lee, J; Shepperd, R; Smith, M1
Garel, N; Joober, R1
Dinnissen, M; Hoekstra, PJ; Popma, A; Reijnen, S; Reurts, EE; Troost, PW1
Devriendt, K; Lambrechts, S; Vogels, A1
Muquebil Ali Al Shaban Rodríguez, OW; Pérez Castro, P1
Arshad, E; Deb, S; Deb, T; Farmah, BK; Roy, M; Unwin, GL1
Adler, BA; Early, M; Erickson, CA; McDougle, CJ; Minshawi, N; Shaffer, R; Wink, LK1
Marshall, PB; Mellman, TA; Nguyen, SX1
Campistol, J; Darling, A; Perez-Duenas, B; Poo, P1
Caroff, SN; Hammerman, S; Lam, C1
Alla, L; Sabaratnam, M; Shastri, M1
Demb, H; Valicenti-McDermott, MR1
Lee, C; Lee, CU; Lim, HK; Pae, CU1

Reviews

2 review(s) available for aripiprazole and Deficiency, Mental

ArticleYear
The effectiveness of aripiprazole in the management of problem behaviour in people with intellectual disabilities, developmental disabilities and/or autistic spectrum disorder--a systematic review.
    Research in developmental disabilities, 2014, Volume: 35, Issue:3

    Topics: Aggression; Antipsychotic Agents; Aripiprazole; Child Development Disorders, Pervasive; Developmental Disabilities; Humans; Intellectual Disability; Mental Disorders; Piperazines; Quinolones; Self-Injurious Behavior; Treatment Outcome

2014
[Medication-related oculogyric crises: a description of four cases and a review of the literature].
    Revista de neurologia, 2013, Feb-01, Volume: 56, Issue:3

    Topics: Adolescent; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Child; Child Behavior Disorders; Child, Preschool; Dopamine; Dopamine Antagonists; Down Syndrome; Dyskinesia, Drug-Induced; Dystonic Disorders; Electroencephalography; Epilepsy; Female; Fragile X Syndrome; Humans; Intellectual Disability; Isoxazoles; Male; Methotrimeprazine; Ocular Motility Disorders; Paliperidone Palmitate; Piperazines; Pyrimidines; Quinolones; Risperidone; Substance Withdrawal Syndrome; Translocation, Genetic; Valproic Acid

2013

Other Studies

11 other study(ies) available for aripiprazole and Deficiency, Mental

ArticleYear
Recognising side effects of antipsychotics in children with intellectual disabilities.
    BMJ case reports, 2023, Jan-04, Volume: 16, Issue:1

    Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Child; Drug-Related Side Effects and Adverse Reactions; Humans; Intellectual Disability; Risperidone

2023
Treatment of first-episode psychosis in patients with autism-spectrum disorder and intellectual deficiency
    Journal of psychiatry & neuroscience : JPN, 2019, Nov-01, Volume: 44, Issue:6

    Topics: Adolescent; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Delusions; Dystonia; Female; Hallucinations; Humans; Hypnotics and Sedatives; Intellectual Disability; Lorazepam; Loxapine; Olanzapine; Paranoid Disorders; Psychotic Disorders; Quetiapine Fumarate; Tourette Syndrome

2019
Aripiprazole in youth with intellectual disabilities: A retrospective chart study.
    Journal of intellectual disabilities : JOID, 2021, Volume: 25, Issue:4

    Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Child; Humans; Intellectual Disability; Piperazines; Quinolones; Retrospective Studies

2021
Low-Dose Aripiprazole and Risperidone for Treating Problem Behavior in Children With Pitt-Hopkins Syndrome.
    Journal of clinical psychopharmacology, 2018, Volume: 38, Issue:3

    Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Child; Facies; Female; Humans; Hyperventilation; Intellectual Disability; Problem Behavior; Risperidone

2018
[Aripiprazole in the treatment of patients with intellectual disability and elevated prolactin levels].
    Semergen, 2019, Volume: 45, Issue:6

    Topics: Antipsychotic Agents; Aripiprazole; Humans; Intellectual Disability; Prolactin

2019
Drug-refractory aggression, self-injurious behavior, and severe tantrums in autism spectrum disorders: a chart review study.
    Autism : the international journal of research and practice, 2015, Volume: 19, Issue:1

    Topics: Adolescent; Adult; Aggression; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Child; Child Development Disorders, Pervasive; Child, Preschool; Female; Humans; Intellectual Disability; Male; Middle Aged; Pilot Projects; Piperazines; Quinolones; Retrospective Studies; Risk Factors; Risperidone; Self-Injurious Behavior; Treatment Failure; Young Adult

2015
Neuroleptic malignant syndrome with the addition of aripiprazole to olanzapine.
    The American journal of psychiatry, 2008, Volume: 165, Issue:11

    Topics: Adult; Aggression; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Benztropine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Intellectual Disability; Male; Neuroleptic Malignant Syndrome; Neurologic Examination; Olanzapine; Piperazines; Quinolones; Risk Factors

2008
Neuroleptic malignant syndrome and aripiprazole.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2006, Volume: 45, Issue:6

    Topics: Adolescent; Anti-Anxiety Agents; Antipsychotic Agents; Aripiprazole; Depressive Disorder; Female; Humans; Intellectual Disability; Lorazepam; Neuroleptic Malignant Syndrome; Piperazines; Quinolones; United States

2006
Aripiprazole use in individuals with intellectual disability and psychotic or behavioural disorders: a case series.
    Journal of psychopharmacology (Oxford, England), 2006, Volume: 20, Issue:6

    Topics: Adolescent; Aged; Antipsychotic Agents; Aripiprazole; Autistic Disorder; Female; Humans; Intellectual Disability; Male; Mental Disorders; Middle Aged; Piperazines; Psychotic Disorders; Quinolones; Schizophrenia; Schizophrenia, Paranoid

2006
Clinical effects and adverse reactions of off-label use of aripiprazole in children and adolescents with developmental disabilities.
    Journal of child and adolescent psychopharmacology, 2006, Volume: 16, Issue:5

    Topics: Adolescent; Aggression; Antipsychotic Agents; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Body Mass Index; Child; Child Behavior Disorders; Child, Preschool; Dose-Response Relationship, Drug; Drug Approval; Female; Follow-Up Studies; Humans; Impulsive Behavior; Intellectual Disability; Male; Mood Disorders; Piperazines; Quinolones; Reactive Attachment Disorder; Self-Injurious Behavior; Sleep Wake Disorders

2006
Tardive dystonic symptoms associated with aripiprazole treatment.
    Progress in neuro-psychopharmacology & biological psychiatry, 2008, Feb-15, Volume: 32, Issue:2

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Comorbidity; Dyskinesia, Drug-Induced; Dystonia; Humans; Intellectual Disability; Male; Ocular Motility Disorders; Piperazines; Quinolones; Schizophrenia

2008